You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR LUVERIS

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Luveris

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00328926 ↗	Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])	Terminated	EMD Serono	Phase 4	2006-03-01	Sponsor has decided to discontinue Luveris® in the United States (US) due to level of customer demand for this product, and not due to any efficacy or safety concerns.
NCT00439829 ↗	Synchronization of Follicle Wave Emergence and Ovarian Stimulation	Completed	Royal University Hospital Foundation	Phase 4	2007-02-01	The objective of the study is to elucidate the effect of synchronizing initiation of ovarian stimulation treatment with follicular wave emergence in poor responder patients undergoing IVF/ICSI and ET. We hypothesize that initiating treatment on day 1 versus day 4 of the cycle will increase the number of follicles recruited and oocytes retrieved.
NCT00439829 ↗	Synchronization of Follicle Wave Emergence and Ovarian Stimulation	Completed	University of Saskatchewan	Phase 4	2007-02-01	The objective of the study is to elucidate the effect of synchronizing initiation of ovarian stimulation treatment with follicular wave emergence in poor responder patients undergoing IVF/ICSI and ET. We hypothesize that initiating treatment on day 1 versus day 4 of the cycle will increase the number of follicles recruited and oocytes retrieved.
NCT00553293 ↗	Nordic Luveris Study	Completed	Helse Fonna	Phase 4	2003-08-01	To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
NCT00553293 ↗	Nordic Luveris Study	Completed	Herlev Hospital	Phase 4	2003-08-01	To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
NCT00553293 ↗	Nordic Luveris Study	Completed	Holbaek Sygehus	Phase 4	2003-08-01	To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Luveris

Condition Name

Chart
Table

Condition Name for Luveris
Intervention	Trials
Infertility	11
Ovulation Induction	3
Sleep Restriction	2
Ovarian Stimulation	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Luveris
Intervention	Trials
Infertility	16
Hypogonadism	4
Infertility, Female	3
Obesity	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Luveris

Trials by Country

Map
Table

Trials by Country for Luveris
Location	Trials
United States	6
Spain	4
China	3
Canada	2
Italy	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Luveris
Location	Trials
California	2
New Jersey	2
Colorado	1
Massachusetts	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Luveris

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Luveris
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	5
Phase 2	6
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Luveris
Clinical Trial Phase	Trials
Completed	11
Terminated	6
Unknown status	3
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Luveris

Sponsor Name

Chart
Table

Sponsor Name for Luveris
Sponsor	Trials
Merck KGaA	7
Merck KGaA, Darmstadt, Germany	7
EMD Serono	3
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Luveris
Sponsor	Trials
Other	33
Industry	23
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.